Sep 25, 2025
The FDA's crusade against 7-OH, a natural derivative used by thousands as a safe alternative to opioids, is the latest proof that our federal health agencies are driven more by political optics than science or compassion.
Sep 18, 2025
Dr. Vinay Prasad's reinstatement at the FDA is a disturbing signal that politics, not policy, drives our health reforms.
Sep 11, 2025
President Trump’s second term offers a historic opportunity to usher in a new era for American aviation. But to achieve that vision, every key appointment must be free of distractions and fully focused on advancing U.S. policy.
Aug 18, 2025
If America is to restore domestic manufacturing and strengthen national security, it needs clear and consistent standards for foreign investment, ones that protect American workers, demand transparency, and prioritize long-term health of vital industries.
Jul 25, 2025
China is investing billions into its biomedical infrastructure. European regulators are vying to become the global standard-setters. If the U.S. slows down now, if we revert to the "caution-first, innovation-later" mindset, we risk ceding ground.
Jun 11, 2025
Last month, the U.S. Senate convened a long-overdue hearing to investigate the claims practices of major insurance companies following recent natural disasters.
Jun 5, 2025
In an era defined by geopolitical uncertainty, volatile markets and rapid technological transformation, the institutions that endure are those led by people who don't just adapt - they drive change. Howard Lutnick is one of those people.
Feb 25, 2025
Another insidious CCP tactic is the use of lawfare: weaponizing the legal system to target U.S. citizens and entities who challenge Beijing. One of the most troubling aspects of CCP aggression is its reach into foreign nations, where it targets dissidents.